FDA Takes Steps to Maintain Newborn Access to Life-Saving Starter Nutrition Products
发生了什么
The U.S. Food and Drug Administration today announced it is taking action, consistent with the Trump administration’s commitment to protecting vulnerable patients and maintaining access to critical medical products, to help address a potential supply gap of neonatal starter parenteral nutrition (PN)
摘要按规则整理自下方来源原文